Recent

% | $
Quotes you view appear here for quick access.

Pacific Biosciences of California, Inc. Message Board

  • riotcow riotcow Nov 30, 2011 4:38 PM Flag

    The best technology eventually wins out

    Illumina will remain the workhorse sequencer, but anyone who has used the Pacific Biosciences RS knows that it is a step above any current technology. The company will still lose money into 2012-2013, but unless another technology appears, the RT sequencing idea will be ubiquitous in every large genome center and if it can really sequence methylated bases, then I'd expect it to be adopted by commercial sequencing firms like DeWalch.

    I rarely make predictions out in the open but come back to this post on Christmas 2012, and the PPS will be sitting at $8-12.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PACB
5.55-0.14(-2.46%)Aug 3 4:00 PMEDT